125 related articles for article (PubMed ID: 18441003)
1. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.
Coppo R
Nephrol Dial Transplant; 2008 Jun; 23(6):1793-6. PubMed ID: 18441003
[No Abstract] [Full Text] [Related]
2. New treatment strategies in idiopathic nephrotic syndrome.
Ulinski T; Aoun B
Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
[TBL] [Abstract][Full Text] [Related]
3. Ofatumumab for rituximab-resistant nephrotic syndrome.
Basu B
N Engl J Med; 2014 Mar; 370(13):1268-70. PubMed ID: 24670185
[No Abstract] [Full Text] [Related]
4. [Immunosuppressive therapies for refractory nephrotic syndrome].
Mitarai T
Nihon Jinzo Gakkai Shi; 2010; 52(7):924-7. PubMed ID: 21077342
[No Abstract] [Full Text] [Related]
5. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
6. Childhood nephrotic syndrome--current and future therapies.
Greenbaum LA; Benndorf R; Smoyer WE
Nat Rev Nephrol; 2012 Jun; 8(8):445-58. PubMed ID: 22688744
[TBL] [Abstract][Full Text] [Related]
7. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
[TBL] [Abstract][Full Text] [Related]
8. Should we consider MMF therapy after rituximab for nephrotic syndrome?
Filler G; Huang SH; Sharma AP
Pediatr Nephrol; 2011 Oct; 26(10):1759-62. PubMed ID: 21533869
[TBL] [Abstract][Full Text] [Related]
9. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
Ulinski T; Aoun B
Curr Med Chem; 2010; 17(9):847-53. PubMed ID: 20156172
[TBL] [Abstract][Full Text] [Related]
10. The treatment of lupus nephritis.
D'Cruz DP; Hughes GR
BMJ; 2005 Feb; 330(7488):377-8. PubMed ID: 15718519
[No Abstract] [Full Text] [Related]
11. [Use of Cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis].
Dudzik B; Kaczmarczyk I; Radziszewski A; Sułowicz W
Przegl Lek; 2001; 58(7-8):798-804. PubMed ID: 11769390
[TBL] [Abstract][Full Text] [Related]
12. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.
Sharma AP; Filler G
Pediatr Nephrol; 2009 Feb; 24(2):423-4. PubMed ID: 18853197
[No Abstract] [Full Text] [Related]
13. [Treatment of idiopathic membranous nephropathy].
Passerini P
G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
[TBL] [Abstract][Full Text] [Related]
14. Improved outcomes in nephrotic syndrome.
Appel GB
Cleve Clin J Med; 2006 Feb; 73(2):161-7. PubMed ID: 16478040
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of nephrotic syndrome in the adult].
Gero L
Orv Hetil; 2006 Dec; 147(48):2313-8. PubMed ID: 17256632
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of steroid-unresponsive nephrotic syndrome.
Del Rio M; Kaskel F
Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
[TBL] [Abstract][Full Text] [Related]
17. [Systemic management of autoimmune anterior uveitis].
Bachta A; Tłustochowicz M
Klin Oczna; 2005; 107(10-12):710-4. PubMed ID: 16619827
[TBL] [Abstract][Full Text] [Related]
18. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
Yang T; Nast CC; Vo A; Jordan SC
Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
[No Abstract] [Full Text] [Related]
19. Evolving new therapies of autoimmune hepatitis.
Vierling JM; Flores PA
Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of steroid-sensitive nephrotic syndrome.
Hodson EM; Alexander SI
Curr Opin Pediatr; 2008 Apr; 20(2):145-50. PubMed ID: 18332709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]